[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100474646":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":56,"collaborators":58,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":24,"eligibilityCriteria":68,"healthyVolunteers":69,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":24,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":81,"overallStatus":39,"whyStopped":24,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Montefiore Medical Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Androgenetic Alopecia","EXPERIMENTAL","The parameters of the laser will be set according to optimal operation protocol and in accordance with guidelines set forth by Sciton. Each laser treatment will take approximately 10 to 15 minutes per subject to target androgenetic alopecia.",[13],"Device: Sciton HALO 1470nm Non-ablative laser",{"label":15,"type":10,"description":16,"interventionNames":17},"Scarring Alopecia","The parameters of the laser will be set according to optimal operation protocol and in accordance with guidelines set forth by Sciton. Each laser treatment will take approximately 10 to 15 minutes per subject to target scarring alopecia.",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DEVICE","Sciton HALO 1470nm Non-ablative laser","Patients will be treated with the 1470nm non-ablative laser.",[9,15],null,[26],{"name":27,"affiliation":28,"role":29},"Kseniya Kobets, MD","Albert Einstein College of Medicine Montefiore Medical Center","PRINCIPAL_INVESTIGATOR",[31],{"name":32,"role":33,"phone":34,"phoneExt":24,"email":35},"Anika Jallorina, BS","CONTACT","618-704-8716","ajallorina@montefiore.org",[37],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Montefiore Einstein Advanced Care","RECRUITING","Elmsford","New York","10523","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-73.82013,41.0551,{"lat":49,"lon":48},[52],{"name":53,"role":33,"phone":54,"phoneExt":24,"email":55},"Gabriela Gjini","914-457-4130","ggjini@montefiore.org",{"type":57,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR",[59],{"name":60,"class":61},"Sciton","INDUSTRY","100474646","1470nm-laser-for-the-treatment-of-androgenetic-alopecia-and-scarring-alopecia-100474646",false,"NCT05460611","1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia","A Pilot Study Evaluating the Safety and Efficacy of a 1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia","Inclusion Criteria:\n\n* Healthy males and females, ≥ 18 years of age at time of informed consent, seeking treatment for hair loss\n* Subject must voluntarily sign and date an IRB approved informed consent form\n* Subjects with diagnosis of biopsy proven androgenetic alopecia or scarring alopecia with hair loss recorded over the past 6 months\n* Subjects must have a stable hair loss treatment regimen with a plateau in results for at least 3 months\n* Able to read, understand and voluntarily provide written informed consent\n* Subject is determined to be healthy, non-smoker who agrees not to make any changes to their daily hair treatment regimen during the study\n* Subjects able and willing to comply with the treatment protocol and follow-up schedule and requirements\n* Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period\n\nExclusion Criteria:\n\n* Subject does not have the capacity to consent to the study\n* Subject has other types of alopecia of the scalp like alopecia areata\n* History of intralesional steroid injections to the scalp in the last 12 months\n* Pregnant women\n* Any medical condition that in the consideration of the investigator, would present an increased risk of a photosensitivity reaction to the subject\n* Any previous surgical procedure in the treatment area in the past 12 months, or major surgery in the last 6 months\n* Allergy or history of prior reaction to lidocaine\n* History of immunosuppression\u002Fimmune deficiency disorders (including AIDS and HIV infection), and\u002For any history of systemic chemotherapy for prior 12 months\n* History or current use of the following prescription medications:\n\n  i. Immunosuppressive medications\u002Fbiologics, 6 months prior to and during the study ii. Accutane or other systemic retinoids within the past twelve months\n* Smoking or vaping in the past 12 months\n* History of uncontrolled hyperlipidemia, diabetes mellitus, hepatitis, or bleeding disorders\n* History of major depressive disorders or endocrine disorders including but not limited to; hypothyroidism, Hashimoto's thyroiditis, or hyperthyroidism",true,"ALL","18 Years","99 Years",{"count":74,"type":75},10,"ESTIMATED","INTERVENTIONAL",[78],"NA","Single-center, open-label, baseline-controlled, pilot study evaluating the use of a Nonablative 1470 nm laser for the treatment of androgenetic alopecia and scarring alopecia.",[15,9],[82,83],"alopecia","laser","2026-06-09",{"date":86,"type":87},"2026-06-11","ACTUAL",{"date":89,"type":87},"2023-12-07",{"date":91,"type":75},"2028-07",{"name":5,"class":6},1]